Medical News

RSS

Florida Institute of Technology assists licensing CDNI-Glu compound to UK company

As a national research university, Florida Institute of Technology not only involves its students in research, but also seeks to license and patent its many innovations. An example of recently licensed university technology is a chemical compound that facilitates the work of neuroscientists in the laboratory.Associate Professor Nasri Nesnas was familiar as a chemist with the chemical compound CDNI-Glu, a commonly used laboratory research tool. Most often, neuroscientists use it to study the brain's neural networks by improving the localization of synaptic stimulation

17 Jul 2010

IAS announces winners of four scientific awards to be presented at AIDS 2010

The International AIDS Society (IAS) announced today the ten winners of four prestigious scientific awards, to be presented at plenary sessions during the XVIII International AIDS Conference (AIDS 2010). Presented by the IAS and partners, these awards recognize scientists involved in innovative HIV and AIDS research throughout the world. "The quality of work represented by the 2010 awardees is remarkable," said IAS President Julio Montaner. "The IAS hopes to draw the world's attention to these individuals and to their significant scientific accomplishments, as well as to the continued need for innovation in all of the major areas of HIV and AIDS research, represented by the six conference programme tracks."

17 Jul 2010

Resveratrol concentration impacts cancer risk mitigation: Study

Agricultural Research Service (ARS) chemist Thomas Wang, who specializes in cancer prevention research, has reported evidence that for some dietary compounds, length of exposure over time may be key to whether or not ingestion leads to a beneficial, or detrimental, effect.Scientists do not know exactly why one person develops cancer and another does not. But they do know that certain nutrients might increase or decrease cancer risk. There are "layers" of factors involved in the development of cancer, and Wang is studying the layers involving peoples' diet complexity and gene expression.

17 Jul 2010

ICON opens purpose-built clinical pharmacology unit within CMFT campus

ICON plc,, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the official opening of a purpose-built clinical pharmacology unit within the Central Manchester University Hospitals Foundation Trust (CMFT) campus in Manchester, UK. Initial studies in the unit utilising translational medicine methodologies to expedite drug development projects began in June, and already 110 volunteers have participated in studies there.

17 Jul 2010

Pacific Shore releases clinical trial results for Burner Balm lip balm

Pacific Shore Holdings, Inc., today announced the release of the highly anticipated clinical trial results for Burner Balm lip balm. According to lead clinical investigator, Dr. David E. Toomey, who has orchestrated a multitude of clinical trials for some of the top pharmaceutical manufacturers in the United States, "Over a twelve week period, 120 study participants who were overweight participated in the study. The Burner Balm group lost an average of 7 to 9 pounds versus the placebo group who lost an average of 1.43 to 1.64 pounds in the 12 week period.

17 Jul 2010

HealthCare Appraisers opens new office in Wayne, Pennsylvania

HealthCare Appraisers, Inc. (HAI) announced today that the firm has opened a new office in the Philadelphia area. The new office, in Wayne, Pennsylvania, is part of HAI's continued office expansion to provide fair market value (FMV) analysis and valuation services to the healthcare and life sciences industries nationwide.

17 Jul 2010

Cage type affects laboratory mice brain

Researchers at the University of Colorado's Anschutz Medical Campus have found the brains of mice used in laboratories worldwide can be profoundly affected by the type of cage they are kept in, a breakthrough that may require scientists to reevaluate the way they conduct future experiments.

17 Jul 2010

Aetna awards $75,000 grant to support Judge Glenda Hatchett's ParentPowerNow! anti-obesity program

Aetna announced today it will support Judge Glenda Hatchett's ParentPowerNow! anti-obesity program. "Parent Power Now!" is an online community of people interested in working together and learning more about parenting. Aetna has awarded a $75,000 grant and will provide health content for the ParentPowerNow! website, guest speakers to address healthy living on Judge Hatchett's live website radio program, and support for health events scheduled around the country.

17 Jul 2010

Study examines HIV-positive patients' death risk at CD4 counts above 350

"Having HIV appears to be associated with a greater risk of death, even when the immune system is relatively robust and patients have not started treatment," according to a study published Friday in the Lancet, MedPage Today reports (Smith, 7/15).

17 Jul 2010

Gluten free diet reduces inflammation, improves digestion

In 2008, the Garmin-Transitions US Cycling Team experimented with a gluten free diet as a way to improve performance by reducing inflammation, which is important for weeks-long races. The experiment was a success.

17 Jul 2010

MJO Staffing, U.S. Colleges of Health & Human Services announce strategic business collaboration

MJO Staffing, Inc. and U.S. Colleges of Health & Human Services announced today the creation of a strategic alliance. This business collaboration is designed to expand the opportunities for both students and recent graduates with additional internship and externship programs while teaming up with MJO Staffing Inc. to expand their employee pool of qualified talent. MJO Staffing will track the professional progression of experience for graduates maximizing their placement opportunities into a rewarding career.

17 Jul 2010

Pain medication abuse soars

The Associated Press: "A new government study finds a 400 percent increase in the number of people admitted to treatment for abusing prescription pain medication. The increase in substance abuse among people ages 12 and older was recorded during the 10-year-period from 1998 to 2008. It spans every gender, race, ethnicity, education and employment level, and all regions of the country" (7/15).

17 Jul 2010

Apicore announces successful conclusion of Somerset API manufacturing plant's FDA inspection

Apicore LLC announced today that the U.S. Food and Drug Administration (FDA) completed an inspection of its API manufacturing plant in Somerset, New Jersey on July 13, 2010.

17 Jul 2010

Epizyme publishes two new review papers on epigenetics

Epizyme, Inc., a company leading the discovery and development of first-in-class, targeted cancer therapeutics against epigenetic targets, announced today the publication of two new review papers in the area of epigenetics. Together, the articles provide an overview of the major epigenetic enzyme classes, as well as chemical biology approaches for discovering small molecule inhibitors of these epigenetic enzymes, and demonstrate Epizyme's scientific leadership in the area of epigenetics.

17 Jul 2010

ArmaGen uses BBB molecular Trojan horse platform technology to create brain penetrating form of human EPO

Human erythropoietin (EPO) is a potent neuroprotective agent for multiple brain disorders, including stroke, brain and spinal cord injury, and Parkinson's disease. However, EPO drug development for the brain is limited, because EPO does not cross the blood-brain barrier (BBB). In acute stroke or brain injury, the BBB is intact in the early hours after the insult when neuroprotection is still possible. Therefore, large molecule biopharmaceuticals such as EPO must be re-engineered to enable BBB transport.

17 Jul 2010

Millipore Corporation exchanges common stock with Merck

Millipore Corporation, a leading provider of technologies, tools and services for the global life science industry, today announced that Merck KGaA ("Merck") has completed its acquisition of Millipore (the "Acquisition") as of July 14, 2010. As part of the transaction, all issued and outstanding shares of Millipore common stock were exchanged for $107 per share in cash.

17 Jul 2010

Cleveland Clinic to provide heart care in Chicago; Johns Hopkins increases primary care in D.C. area

Chicago Tribune: "In a move likely to shake up the market for heart care in the Chicago area, the Cleveland Clinic's cardiac surgery program has signed an affiliation agreement with Central DuPage Hospital in west suburban Winfield. The deal, announced Thursday, is designed to enhance the heart care provided at the 313-bed hospital and potentially bring Cleveland Clinic patient referrals at a time when fewer heart surgeries are needed than were a decade ago.

17 Jul 2010

Epocrates announces filing of registration statement for proposed initial common stock public offering

Epocrates, Inc., a leading provider of mobile drug reference tools and interactive services to healthcare professionals and the healthcare industry, today announced it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of its common stock.

17 Jul 2010

HTA acquires $8.14M medical office building in Stockbridge, Georgia

Healthcare Trust of America, Inc., a self-managed, non-traded, real estate investment trust, announced the acquisition of a medical office building located in Stockbridge, Georgia for approximately $8,140,000.

17 Jul 2010

Ronald Reagan UCLA Medical Center ranks first: U.S. News & World Report survey

Ronald Reagan UCLA Medical Center ranks as one of the top five American hospitals -- and the best hospital in the western United States for the 21st consecutive year -- according to a U.S. News & World Report survey that reviewed patient-outcomes data, reputation among physicians and other care-

17 Jul 2010

Medical News

Florida Institute of Technology assists licensing CDNI-Glu compound to UK company

IAS announces winners of four scientific awards to be presented at AIDS 2010

Resveratrol concentration impacts cancer risk mitigation: Study

ICON opens purpose-built clinical pharmacology unit within CMFT campus

Pacific Shore releases clinical trial results for Burner Balm lip balm

HealthCare Appraisers opens new office in Wayne, Pennsylvania

Cage type affects laboratory mice brain

Aetna awards $75,000 grant to support Judge Glenda Hatchett's ParentPowerNow! anti-obesity program

Study examines HIV-positive patients' death risk at CD4 counts above 350

Gluten free diet reduces inflammation, improves digestion

MJO Staffing, U.S. Colleges of Health & Human Services announce strategic business collaboration

Pain medication abuse soars

Apicore announces successful conclusion of Somerset API manufacturing plant's FDA inspection

Epizyme publishes two new review papers on epigenetics

ArmaGen uses BBB molecular Trojan horse platform technology to create brain penetrating form of human EPO

Millipore Corporation exchanges common stock with Merck

Cleveland Clinic to provide heart care in Chicago; Johns Hopkins increases primary care in D.C. area

Epocrates announces filing of registration statement for proposed initial common stock public offering

HTA acquires $8.14M medical office building in Stockbridge, Georgia

Ronald Reagan UCLA Medical Center ranks first: U.S. News & World Report survey

Squid™ Full Range Pipette: Reduce pipette changes, bench clutter, and calibration burden

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

Latest News